Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2019; 15
DOI: 10.1055/s-0044-1798237
PO IMPRESSO
TEMÁRIO: RADIOTERAPIA (SUBMISSÃO PARA O XXI CONGRESSO DA SOCIEDADE BRASILEIRA DE RADIOTERAPIA) CÓDIGO

STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LUNG TUMORS: EXPERIENCE OF THE NATIONAL CANCER INSTITUTE JOSÉ DE ALENCAR

Thomas Éric Rabelo dos Santos
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Carolina Seixas Dubeux
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Claudia Regina Scaramello Hadlich Willis Fernandez
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Anna Myrian Tamm Lannes Vieira
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Felipe Erlich
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Guilherme Leal Rebello
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
,
Maria Izabel Sathler Pinel
1   INSTITUTO NACIONAL DE CÂNCER JOSÉ DE ALENCAR
› Author Affiliations
 

    Introduction: Stereotactic Body Radiation Therapy (SBRT) is the treatment of choice for patients with early stage non-surgical lung tumor as well as for oligometastases. However, this technique requires the availability of high technology equipment and professional training for its implementation. There are few reports of experience in services with exclusive care by the Unified Health System (SUS). Objective: To describe the profile of patients treated with the lung SBRT technique at the National Cancer Institute José de Alencar. Methods: The patients were diagnosed with a diagnosis of lung tumor (ICD 10 C34) from January 2015 to December 2018. Data were examined by electronic and physical medical records, as well as data from the Eclipse® Planning System database version 13.6. Results: We evaluated 912 patients with topographic diagnosis of lung tumors, of which 46 underwent SBRT and are the target of the study. According to age distribution were 9 in 2015, 8 in 2016, 15 in 2017 and 14 in 2018. They were more prevalent in males (61%). The median age was 69.5 years and the histological types were: adenocarcinoma (63%), squamous carcinoma (29%), sarcoma (2%), other histologies (4%) and without report (2%). Regarding laterality, there were 26 left, 18 right and 2 bilateral lesions. Regarding the location in relation to the main bronchial tree: 37 were peripheral (77%), 9 were central (19%), 2 were ultra central (4%). The most commonly used dose regimens were: 3x 18 Gy (50%), 5x 10 Gy (26%), 5x 6 Gy (13%) and others(11%), all procedures being performed on the Trilogy® Linear Accelerator. Conclusion: SBRT for lung tumors has been increasing in recent years. The most incident treatment profile in this institution is men with primary left lung adenocarcinoma and peripheral location.


    No conflict of interest has been declared by the author(s).

    Contato:

    Thomas Éric Rabelo dos Santos

    Publication History

    Article published online:
    23 October 2019

    © 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

    Thieme Revinter Publicações Ltda.
    Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

    Bibliographical Record
    Thomas Éric Rabelo dos Santos, Carolina Seixas Dubeux, Claudia Regina Scaramello Hadlich Willis Fernandez, Anna Myrian Tamm Lannes Vieira, Felipe Erlich, Guilherme Leal Rebello, Maria Izabel Sathler Pinel. STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LUNG TUMORS: EXPERIENCE OF THE NATIONAL CANCER INSTITUTE JOSÉ DE ALENCAR. Brazilian Journal of Oncology 2019; 15.
    DOI: 10.1055/s-0044-1798237